The global market for vitamin D ingredients is expected to grow at a CAGR of 7.2% between 2025 and 2035, reaching USD 3.2 ...

Dr. Philip Dormitzer, former global head of vaccine research and development at Pfizer, has been subpoenaed by the House Judiciary Committee as it investigates Pfizer’s alleged delay in the release of ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

Recent health-related developments highlight significant shifts in the pharma industry and governance: France's Carmat files ...

GSK plc (NYSE: GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...

Leading companies spent $1.4 billion upfront on licensing deals and embarked on vast R&D programs. Clinical setbacks mean ...

Bharat Biotech and GSK announce price reduction for the world's first malaria vaccine to under $5. This move aims to improve ...

Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving ...

On June 5–6, the Global Think-tank on Steatotic Liver Disease1 convened a multidisciplinary group of 125 participants in Barcelona, including clinicians, patient advocates, public health experts, and ...